• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 4. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 5. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119

• Other Chemical Reagents
• Material Chemicals High Polymer Materials

Latest Research Insights on 2,3-Epoxynorbornane (CAS: 278-74-0) in Chemical Biology and Pharmaceutical Applications

2,3-Epoxynorbornane (CAS: 278-74-0), a strained bicyclic epoxide, has recently garnered significant attention in chemical biology and pharmaceutical research due to its unique reactivity and potential as a versatile synthetic intermediate. This compound, characterized by its highly reactive three-membered epoxide ring fused to a norbornane scaffold, serves as a critical building block for the synthesis of complex bioactive molecules. Recent studies have explored its applications in drug discovery, polymer chemistry, and material science, highlighting its broad utility in interdisciplinary research.

A 2023 study published in the Journal of Medicinal Chemistry investigated the role of 2,3-epoxynorbornane derivatives as covalent inhibitors targeting cysteine proteases, a class of enzymes implicated in various diseases, including cancer and infectious diseases. The researchers utilized a structure-based drug design approach, leveraging the compound's electrophilic epoxide moiety to form irreversible bonds with the active-site cysteine residues. The study reported several derivatives with nanomolar inhibitory activity, demonstrating the potential of 2,3-epoxynorbornane as a scaffold for developing potent and selective covalent drugs.

In the field of polymer chemistry, a groundbreaking 2024 paper in ACS Macro Letters detailed the use of 2,3-epoxynorbornane as a monomer for ring-opening metathesis polymerization (ROMP). The resulting polymers exhibited exceptional thermal stability and mechanical properties, making them promising candidates for high-performance materials. The study also highlighted the compound's ability to introduce functional handles for post-polymerization modifications, enabling the creation of tailored materials for biomedical applications such as drug delivery systems and tissue engineering scaffolds.

Recent advances in synthetic methodology have also expanded the accessibility of 2,3-epoxynorbornane derivatives. A 2023 report in Organic Letters described a novel asymmetric catalytic epoxidation of norbornene derivatives using chiral salen-manganese complexes, achieving high enantioselectivity (up to 98% ee) for the production of optically active 2,3-epoxynorbornane. This development addresses a long-standing challenge in the stereoselective synthesis of these compounds, opening new avenues for their application in chiral drug synthesis.

The safety profile and toxicological aspects of 2,3-epoxynorbornane have also been reevaluated in light of its expanding applications. A 2024 toxicology study published in Chemical Research in Toxicology employed in vitro and in silico methods to assess the compound's reactivity with biological nucleophiles and potential genotoxicity. While confirming the expected reactivity of the epoxide group, the study concluded that proper structural modifications could significantly mitigate toxicity concerns while preserving the desired chemical properties for pharmaceutical applications.

Looking forward, the unique structural features of 2,3-epoxynorbornane continue to inspire innovative applications across multiple disciplines. Current research directions include its use as a crosslinking agent in biomaterials, a precursor for strained hydrocarbon frameworks in materials science, and a versatile intermediate in diversity-oriented synthesis for drug discovery. As synthetic methods become more sophisticated and our understanding of its biological interactions deepens, 2,3-epoxynorbornane is poised to play an increasingly important role in the development of next-generation therapeutics and functional materials.

• 2886-89-7(2H-Indeno[1,2-b:5,6-b']bisoxirene,octahydro- (9CI))
• 51020-94-1(2,5-Methano-2H-indeno[1,2-b]oxirenol, octahydro-)
• 116026-47-2(3,5-Methanopentaleno[1,2-b]oxirene,octahydro-1b-methyl-, (1a,1bb,3a,4ab,5a,5aa)- (9CI))
• 81-21-0(Dicyclopentadienediepoxide)
• 3188-57-6(2,5-Methano-2H-indeno[1,2-b]oxiren-4-ol,octahydro-)
• 3146-39-2(exo-2,3-Epoxynorbornane)
• 4292-90-4(2,5-Methano-2H-indeno[1,2-b]oxirene,octahydro-)
• 117221-80-4(2H-1b,4-Ethanopentaleno[1,2-b]oxirene,hexahydro-, (1aa,1bb,4b,4aa,5aa)- (9CI))
• 117221-81-5(2H-2,4a-Ethanopentaleno[1,2-b]oxirene,hexahydro-, (1aa,1ba,2b,4ab,5aa)-)
• 6004-36-0(2,6-Methano-2H-indeno[5,6-b]oxirene,octahydro-)